VXRT
Vaxart, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.40
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- 0.73x
- P/E 2026E
- 1.24x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.67x
- PEG TTM
- 0.01x
- Price / book
- 1.11x
- Price / sales
- 0.38x
- Price / cash flow
- 2.69x
Enterprise value
- Enterprise value
- $35.4M
- EV / sales
- 0.15x
- EV / EBITDA
- 0.75x
- EV / EBIT
- 0.89x
- Market cap
- $91.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026